Möchten Sie immer auf dem neuesten Stand bleiben?

Ad hoc announcement pursuant to Art. 53 LRFull yearNet sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from...

New Delhi, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The global High-speed camera market size is poised to reach a valuation of US$ 7,036.5 million by 2033, up from US$ 4,060.3 million in 2024 at a CAGR of...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P Morgan Healthcare Week in San Francisco

Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High-Speed Camera Market by Spectrum, Component, Frame Rate, Throughput, Resolution, Interface, Application and Region - Market Size, Industry...

Novel paradigm for therapeutics based on RNA splicing modulationLead program in Huntington’s disease Denmark – Odense – 07/01/2025 – Inverna Therapeutics, a novel Danish biotech company at the...

Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Network Operator Capex Forecast: 4Q24 Edition" report has been added to ResearchAndMarkets.com's offering. This forecast presents the latest...

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the “Company”) today announced updated data from its Phase 1/2 Study of ONCT-534 for the treatment of...

LONDON and NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company...

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the “Company”) today announced its decision to discontinue its clinical trials evaluating ONCT-534, its...